Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and safety advantages.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN111675662A details an efficient FeCl3-catalyzed synthesis of 2-trifluoromethyl quinazolinones from isatin, offering cost-effective routes for reliable pharmaceutical intermediate suppliers.
Patent CN111675662B reveals a scalable iron-catalyzed route to 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and reliable supply.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for API manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. Reduces cost in API manufacturing via safe CO sources and cheap nitro substrates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO surrogate. Enhances safety and yield for API intermediates.
Patent CN113045503B discloses a novel Pd-catalyzed carbonylation for 2-CF3 quinazolinones. High-yield, scalable route for API intermediates like Rutaecarpine.
Patent CN112480015B details a safe one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
This patent reveals a novel Pd-catalyzed route for 2-trifluoromethyl quinazolinone, offering high yields and broad substrate scope, enabling cost reduction in pharmaceutical intermediate manufacturing.
This patent reveals a novel, iron-catalyzed route for 2-trifluoromethyl quinazolinone, offering scalable synthesis with high purity and reduced manufacturing costs for pharmaceutical applications.
Patent CN112480015B introduces an innovative one-pot method for synthesizing trifluoromethyl quinazolinones with enhanced scalability and cost reduction potential for pharmaceutical intermediate production.
Novel palladium-catalyzed methodology enables efficient production of high-purity quinazolinone intermediates with enhanced scalability and cost reduction for pharmaceutical manufacturing.
Breakthrough one-pot palladium-catalyzed method for high-purity 2-trifluoromethyl quinazolinone with scalable manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Patent CN112125856A introduces a safer CO-surrogate method for high-purity quinazolinone derivatives with enhanced supply chain reliability and cost efficiency.
Patent CN111675662B enables efficient FeCl3-catalyzed synthesis of high-purity quinazolinone intermediates with significant cost reduction and scalable manufacturing capabilities for global pharma supply chains.
Novel copper-catalyzed synthesis enables high-purity aminoquinazolinone intermediates with enhanced scalability and reduced production costs for pharmaceutical manufacturing.
Patent CN112480015B enables high-purity quinazolinone intermediates through streamlined one-pot synthesis with enhanced supply chain reliability and cost-effective manufacturing scalability.
Patent CN112125856A enables safe scalable production of high-purity quinazolinones eliminating toxic CO gas while improving cost efficiency for pharmaceutical applications.
Innovative Pd-catalyzed one-pot method enables high-purity 2-trifluoromethyl quinazolinone production with simplified manufacturing and enhanced supply chain reliability for pharmaceutical applications.